Zdrowie i gospodarka · 14/05/2021
FDA Establishes Public Docket to Gather Comments on Peptide Clinical Pharmacology
The FDA is seeking public input on the clinical pharmacology of peptides, focusing on effects of hepatic impairment, drug-drug interactions, and immunogenicity, to inform study design and regulatory assessment
Source: Federal Register — Food and Drug AdministrationOpen original release →